Transforming Drug Discovery At Recursion With DDN Ai Platforms
DDN News, June 17th, 2020
June 17, 2020,
Volume 267, Issue 3
With most of the industry fighting mounting drug-discovery costs and time-to-market challenges, Recursion uses new approaches combining scientific and technological approaches
"DDN, the global leader in Artificial Intelligence (AI) and multicloud data management announced its high-performance storage solutions have helped to support broader, faster and more efficient drug discovery research and operations at Recursion, a digital biology company industrializing drug discovery through the combination of automation, artificial intelligence (AI) and machine learning (ML) capabilities to discover novel medicines. Read the Recursion case study that describes the challenges, solution and benefits of the infrastructure, and reveals details of the global-impact work that's taking place in Salt Lake City..."
Read More ...